Correlation Between Cadrenal Therapeutics, and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Lyra Therapeutics, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Lyra Therapeutics.
Diversification Opportunities for Cadrenal Therapeutics, and Lyra Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cadrenal and Lyra is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Lyra Therapeutics
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 0.77 times more return on investment than Lyra Therapeutics. However, Cadrenal Therapeutics, Common is 1.29 times less risky than Lyra Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 1,509 in Cadrenal Therapeutics, Common on August 28, 2024 and sell it today you would lose (153.00) from holding Cadrenal Therapeutics, Common or give up 10.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Lyra Therapeutics
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Lyra Therapeutics |
Cadrenal Therapeutics, and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Lyra Therapeutics
The main advantage of trading using opposite Cadrenal Therapeutics, and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. HCW Biologics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals |
| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |